Literature DB >> 8778153

Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension.

C Fardella1, J A Rodriguez-Portales.   

Abstract

Intracellular calcium has been reported to be increased in essential hypertension, and thought to play a role in its genesis through facilitation of vascular smooth muscle contraction. Since hypertension is more prevalent in primary hyperparathyroidism, intracellular calcium may also be increased in this condition. To investigate whether the hyperparathyroid condition, i.e., hypercalcemia and increased PTH per se, could be associated with high intracellular calcium, we measured intracellular calcium in platelets with the Quin-2 AM fluorometric method in 11 normotensive patients with primary hyperparathyroidism, 15 patients with essential hypertension, and 18 normal controls, all matched for age and sex. We repeated the measurements in 9 of the hyperparathyroid patients after successful surgery. We found that intracellular calcium was higher in normotensive patients with primary hyperparathyroidism than in normal controls (198 +/- 24 vs 113 +/- 11 nM, p < 0.05), but lower than in patients with essential hypertension (198 +/- 24 vs 286 +/- 38 nM, p < 0.05). Successful removal of a parathyroid adenoma decreased intracellular calcium from 215 +/- 22 to 116 +/- 19 nM, (p < 0.01). In the patients with primary hyperparathyroidism, intracellular calcium was strongly correlated with the levels of PTH (r = 0.87, p < 0.01), but not with the total serum calcium levels (r = 0.04, NS). The decrease in intracellular calcium after parathyroidectomy was also strongly correlated with the decrease in PTH (r = 0.84, P < 0.01), but not with the decrease in total serum calcium (r = 0.16, NS). In the patients with essential hypertension, intracellular calcium correlated well with systolic (r = 0.69, p < 0.01), diastolic (r = 0.76, p < 0.01) and especially mean arterial pressure (r = 0.86, P < 0.01). There was no correlation between blood pressure and intracellular calcium in the patients with primary hyperparathyroidism. We conclude that normotensive patients with primary hyperparathyroidism, as well as patients with essential hypertension, can have increased concentrations of intracellular calcium in platelets. The correction of the hyperparathyroid condition normalizes intracellular calcium concentration. The close correlation between PTH and intracellular calcium suggests that PTH may act as a ionophore for calcium entry into cells. Whether the increased levels of intracellular calcium may reflect a pre-hypertensive condition in normotensive patients with primary hyperparathyroidism remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8778153     DOI: 10.1007/BF03349828

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

1.  Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy.

Authors:  P Erne; P Bolli; E Bürgisser; F R Bühler
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

2.  Parathyroid hormone inhibits human platelet function.

Authors:  G Remuzzi; A Benigni; P Dodesini; A Schieppati; M Livio; E Poletti; G Mecca; G de Gaetano
Journal:  Lancet       Date:  1981-12-12       Impact factor: 79.321

3.  Mode of filament assembly of myosins from muscle and nonmuscle cells.

Authors:  H Hinssen; J D'Haese; J V Small; A Sobieszek
Journal:  J Ultrastruct Res       Date:  1978-09

4.  Stimulation of inositol trisphosphate and diacylglycerol production in renal tubular cells by parathyroid hormone.

Authors:  K A Hruska; D Moskowitz; P Esbrit; R Civitelli; S Westbrook; M Huskey
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

5.  Action of parathyroid extract on arterial blood pressure and on contraction and 45Ca exchange in isolated aorta of the rat.

Authors:  R Schleiffer; A Berthelot; A Gairard
Journal:  Eur J Pharmacol       Date:  1979-09-15       Impact factor: 4.432

6.  Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.

Authors:  R Y Tsien; T Pozzan; T J Rink
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539

7.  Ca2+i:K+i ratio and total intracellular calcium in essential and renal hypertension.

Authors:  W Zidek; C Spieker; H Vetter
Journal:  J Hypertens       Date:  1986-08       Impact factor: 4.844

8.  Primary hyperparathyroidism and hypertension: persistently abnormal pressor sensitivity in normotensive patients after surgical cure.

Authors:  J A Rodríguez-Portales; C Fardella
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

9.  Analysis of calcium handling in erythrocyte membranes of genetically hypertensive rats.

Authors:  M A Devynck; M G Pernollet; A M Nunez; P Meyer
Journal:  Hypertension       Date:  1981 Jul-Aug       Impact factor: 10.190

10.  Human platelet myosin. II. In vitro assembly and structure of myosin filaments.

Authors:  R Niederman; T D Pollard
Journal:  J Cell Biol       Date:  1975-10       Impact factor: 10.539

View more
  11 in total

1.  Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort.

Authors:  E Hagström; P Hellman; E Lundgren; L Lind; J Arnlöv
Journal:  Diabetologia       Date:  2006-12-20       Impact factor: 10.122

Review 2.  Cardiovascular aspects of primary hyperparathyroidism.

Authors:  M D Walker; S J Silverberg
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

3.  Influence of Vitamin D and Parathyroid Hormone on Bone and Metabolic Risk in Women with Previous Gestational Diabetes.

Authors:  M C Serra; A S Ryan
Journal:  Horm Metab Res       Date:  2016-02-16       Impact factor: 2.936

4.  Association of calcium concentration with pulse pressure in older women: data from a large population-based multicentric study.

Authors:  L Mateus-Hamdan; O Beauchet; Y Rolland; A-M Schott; C Annweiler
Journal:  J Nutr Health Aging       Date:  2014-03       Impact factor: 4.075

5.  Hypertension Secondary to PHPT: Cause or Coincidence?

Authors:  Helmut Schiffl; Susanne M Lang
Journal:  Int J Endocrinol       Date:  2011-03-07       Impact factor: 3.257

6.  Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism.

Authors:  P D Broulik; A Brouliková; S Adámek; P Libanský; J Tvrdoň; K Broulikova; J Kubinyi
Journal:  Int J Endocrinol       Date:  2011-02-20       Impact factor: 3.257

7.  Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results.

Authors:  Petramala Luigi; Formicuccia Maria Chiara; Zinnamosca Laura; Marinelli Cristiano; Cilenti Giuseppina; Colangelo Luciano; Panzironi Giuseppe; Cerci Sabrina; Sciomer Susanna; Ciardi Antonio; Cavallaro Giuseppe; De Toma Giorgio; Letizia Claudio
Journal:  Int J Endocrinol       Date:  2012-06-07       Impact factor: 3.257

8.  High prevalence of metabolic syndrome in a mestizo group of adult patients with primary hyperparathyroidism (PHPT).

Authors:  Victoria Mendoza-Zubieta; Gloria A Gonzalez-Villaseñor; Guadalupe Vargas-Ortega; Baldomero Gonzalez; Claudia Ramirez-Renteria; Moises Mercado; Mario A Molina-Ayala; Aldo Ferreira-Hermosillo
Journal:  BMC Endocr Disord       Date:  2015-04-03       Impact factor: 2.763

9.  Association between pre-pregnancy calcium intake and hypertensive disorders during the first pregnancy: the Japan environment and children's study.

Authors:  Hyo Kyozuka; Tsuyoshi Murata; Toma Fukuda; Akiko Yamaguchi; Aya Kanno; Shun Yasuda; Akiko Sato; Yuka Ogata; Masahito Kuse; Mitsuaki Hosoya; Seiji Yasumura; Koichi Hashimoto; Hidekazu Nishigori; Keiya Fujimori
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-28       Impact factor: 3.007

10.  Does vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms.

Authors:  M Iftekhar Ullah; Gabriel I Uwaifo; William C Nicholas; Christian A Koch
Journal:  Int J Endocrinol       Date:  2009-11-10       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.